1Drakatos P, Lykouras D, Sarnpsonas F, et al. Targeting leukotrienes for the treatment of COPD?[J]. Inflamm Allergy Drug Targets,2009,8(4) :297-306. 被引量：1
3Bathoorn E, Liesker JJ, Postma DS, et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation[J]. Int J Chron Obstruct Pulmon Dis,2009,4 : 101-109. 被引量：1
6Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome[J]. Crit Care Med,1995,23(10) :1638-1652. 被引量：1
8Woodruff PG,Albert RK,Bailey WC,et al. Randomized trial of zileuton for treatmerit of COPD exacerbations requiring hospitalization[J]. COPD, 2011,8 ( 1 ):21-29. 被引量：1
9Silkoff PE, Martin D, Pak J, et al. Exhaled nitric oxide correlated with induced sputum findings in COPD[J]. Chest, 2001,119(4) :1049-1055. 被引量：1
10Gueli N, Verrusio W, Linguanti A, et al. Montelukast therapy and psychological distress in chronic obstructive pulmonary disease (COPD): a preliminary report[J]. Arch Gerontol Geriatr,2011,52(1) :e36-39. 被引量：1
